37 related articles for article (PubMed ID: 8041119)
1. Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.
Grigolo B; Mazzetti I; Borzì RM; Hickson ID; Fabbri M; Fasano L; Meliconi R; Facchini A
Clin Exp Immunol; 1998 Dec; 114(3):339-46. PubMed ID: 9844041
[TBL] [Abstract][Full Text] [Related]
2. Chemi-Northern: a versatile chemiluminescent northern blot method for analysis and quantitation of RNA molecules.
McKenney KM; Connacher RP; Dunshee EB; Goldstrohm AC
RNA; 2024 Mar; 30(4):448-462. PubMed ID: 38282416
[TBL] [Abstract][Full Text] [Related]
3. Simple and Fast DNA Based Sensor System for Screening of Small-Molecule Compounds Targeting Eukaryotic Topoisomerase 1.
Petersen KV; Selas A; Hymøller KM; Mizielinski K; Thorsager M; Stougaard M; Alonso C; Palacios F; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Knudsen BR; Tesauro C
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452216
[No Abstract] [Full Text] [Related]
4. Correction to 'Using energy to go downhill-a genoprotective role for ATPase activity in DNA topoisomerase II'.
Nucleic Acids Res; 2024 Feb; 52(3):1525. PubMed ID: 38153185
[No Abstract] [Full Text] [Related]
5. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
Withoff S; van der Zee AG; de Jong S; Hollema H; Smit EF; Mulder NH; de Vries EG
Br J Cancer; 1999 Feb; 79(5-6):748-53. PubMed ID: 10070864
[TBL] [Abstract][Full Text] [Related]
6. A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood.
Helfrich W; ten Poele R; Meersma GJ; Mulder NH; de Vries EG; de Leij L; Smit EF
Br J Cancer; 1997; 76(1):29-35. PubMed ID: 9218728
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
Withoff S; de Vries EG; Keith WN; Nienhuis EF; van der Graaf WT; Uges DR; Mulder NH
Br J Cancer; 1996 Dec; 74(12):1869-76. PubMed ID: 8980384
[TBL] [Abstract][Full Text] [Related]
8. Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.
Withoff S; Keith WN; Knol AJ; Coutts JC; Hoare SF; Mulder NH; de Vries EG
Br J Cancer; 1996 Aug; 74(4):502-7. PubMed ID: 8761362
[TBL] [Abstract][Full Text] [Related]
9. Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer.
Järvinen TA; Kononen J; Pelto-Huikko M; Isola J
Am J Pathol; 1996 Jun; 148(6):2073-82. PubMed ID: 8669491
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cAMP RI alpha mRNA expression in breast cancer: evaluation of quantitative polymerase chain reaction for routine use.
Bartlett JM; Hulme MJ; Miller WR
Br J Cancer; 1996 Jun; 73(12):1538-44. PubMed ID: 8664126
[TBL] [Abstract][Full Text] [Related]
11. Validation of a polymerase chain reaction aided transcript titration assay (PATTY) for topoisomerase II in lung cancer samples.
Dingemans AM; Van Ark-Otte J; Smit EF; Postmus PE; Giaccone G
Anticancer Res; 2000; 20(5B):3549-54. PubMed ID: 11131661
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.
Jensen PB
Dan Med Bull; 1994 Nov; 41(5):475-88. PubMed ID: 7859516
[No Abstract] [Full Text] [Related]
13. Topoisomerase expression in cancer cell lines and clinical samples.
Doyle LA
Cancer Chemother Pharmacol; 1994; 34 Suppl():S32-40. PubMed ID: 8070025
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
